Lagevrio Capsule
NDC Package 0006-5055-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lagevrio (molnupiravir) capsules is no contraindications have been identified based on the limited available data on the emergency use of molnupiravir authorized under this EUA. This formulation utilizes a capsule delivery system. Marketed by Merck Sharp & Dohme Llc, this product is identified by NDC 0006-5055.

Identification & Billing

NDC Package Code
0006-5055-07
Package Description
40 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
00006505507
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
40 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lagevrio
Non-Proprietary Name
Molnupiravir
Substance Name
Molnupiravir
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
No contraindications have been identified based on the limited available data on the emergency use of molnupiravir authorized under this EUA.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Llc
Product Type
Human Prescription Drug
Marketing Category
EMERGENCY USE AUTHORIZATION -
Start Marketing Date
12-23-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0006-5055). Click a package code to view its specific billing and regulatory data.

40 CAPSULE in 1 BOTTLE, PLASTIC
40 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-5055-07 identifies a specific commercial package of 40 capsule in 1 bottle, plastic of Lagevrio, a human prescription drug labeled by Merck Sharp & Dohme Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 40 billable units per package. This capsule is formulated for oral use and contains molnupiravir as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Merck Sharp & Dohme Llc on December 23, 2021. The current certification is valid through December 31, 2026.

How is this Merck Sharp & Dohme Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006505507. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 40 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-5055-07
11-Digit CMS (5-4-2)
00006-5055-07

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.